Hogan Lovells has advised HealthCare Royalty Partners. Goodwin has advised Apnimed, Inc. Apnimed, Inc., a pharmaceutical company focused on developing oral therapies for obstructive sleep apnea...
Apnimed Secures $150 Million Debt Financing and Monetizes SASS Joint Venture Stake
ARCHIMED Acquires Esperion Therapeutics in $1.1 Billion Transaction
Sidley Austin and Moelis & Company have advised ARCHIMED. Goodwin Procter and Centerview Partners have advised Esperion Therapeutics. Akin Gump has advised Pharmakon Advisors. ARCHIMED, a...
Metagenomi’s $94 Million Initial Public Offering
Goodwin assisted Metagenomi on the matter. Preclinical biotech Metagenomi went public on the Nasdaq under the ticker “MGX”, raising $94 million by offering 6.25 million shares...
TELA Bio’s Shares Offering
Troutman Pepper advised TELA Bio on the deal. TELA Bio announced the closing of its previously announced underwritten public offering of 4,600,000 shares of its common...
Century Therapeutics’ Collaboration with Bristol Myers Squibb
Troutman Pepper advised Century Therapeutics on the deal. Century Therapeutics (NASDAQ: IPSC) has announced a research collaboration and license agreement with Bristol Myers Squibb (NYSE: BMY)...